Cabot (NYSE:CBT) Shares Cross Above 200 Day Moving Average - Here's What Happened

Key Points

• Cabot shares moved above their 200-day moving average during Tuesday’s trading, signaling renewed momentum. The stock traded as high as $89.79 and last changed hands at $87.68.
• Analyst views are mixed, but the consensus remains Hold with an average target price of $85.80. Recent actions included a Truist Buy initiation, while JPMorgan kept an Underweight rating and UBS held a Neutral view.
• Cabot beat quarterly earnings expectations and continues to pay a dividend. The company reported $1.61 EPS versus $1.47 expected and announced a quarterly dividend of $0.4725 per share, yielding about 2.2% annually.

Cabot Corporation (NYSE:CBT - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $77.50 and traded as high as $89.79. Cabot shares last traded at $87.68, with a volume of 439,586 shares changing hands.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $68.00 to $70.00 and gave the stock an "underweight" rating in a research report on Wednesday, May 13th. Truist Financial initiated coverage on shares of Cabot in a research report on Monday, June 8th. They set a "buy" rating and a $98.00 price target for the company. UBS Group raised their price objective on Cabot from $81.00 to $86.00 and gave the company a "neutral" rating in a research note on Friday, May 8th. Weiss Ratings reiterated a "hold (c)" rating on shares of Cabot in a report on Tuesday, May 26th. Finally, Wall Street Zen raised Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, June 14th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Cabot currently has a consensus rating of "Hold" and an average target price of $85.80.

Cabot Stock Down 0.2%

The company has a market capitalization of $4.53 billion, a P/E ratio of 16.57, a price-to-earnings-growth ratio of 11.55 and a beta of 0.83. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The stock's fifty day moving average is $85.86 and its 200 day moving average is $77.50.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. During the same quarter last year, the firm earned $1.90 EPS. The company's revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Research analysts predict that Cabot Corporation will post 6.34 EPS for the current fiscal year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Friday, August 28th. Cabot's dividend payout ratio is currently 35.73%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Torren Management LLC purchased a new stake in Cabot in the 4th quarter worth approximately $26,000. Rothschild Investment LLC increased its stake in shares of Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company's stock valued at $27,000 after buying an additional 259 shares during the period. Geneos Wealth Management Inc. raised its holdings in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after acquiring an additional 364 shares in the last quarter. Global Retirement Partners LLC raised its holdings in shares of Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company's stock valued at $33,000 after acquiring an additional 466 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in Cabot in the third quarter worth $38,000. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.